Russia's Sputnik V Covid-19 vaccine shows 97.6% efficacy

20 Apr 2021 (Last Updated April 20th, 2021 10:20)
The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have reported that the Sputnik V Covid-19 vaccine showed a 97.6% efficacy.
Share Article
Disease incidence among unvaccinated adults was 1.1% from the 35th day after launching mass vaccination in the country. Credit: Alexey Fedenkov / Pixabay.
The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have reported that the Sputnik V Covid-19 vaccine showed a 97.6% efficacy.
This was based on the analysis of data on disease infection rate among people receiving both shots of the vaccine.

Related Keywords

China , India , Russia , Hualan , Anhui , Russians , Chinese , Russian , Alexander Gintsburg , Kirill Dmitriev , Gamaleya Research Institute Of Epidemiology , Gamaleya National Research Center , Russian Direct Investment Fund , Gamaleya Research Institute , Microbiology Director Alexander Gintsburg , Hualan Biological Bacterin , Virchow Biotech , சீனா , இந்தியா , ரஷ்யா , அன்ஹுய் , ரஷ்யர்கள் , சீன , ரஷ்ய , ரஷ்ய நேரடி முதலீடு நிதி ,